Citius Pharmaceuticals News

8-K: Current report

May 21 16:10 ET

10-Q: Quarterly report

May 14 16:43 ET

8-K: Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2024 Financial Results and Provides Business Update

May 14 16:32 ET

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(4.8%)

May 8 14:25 ET

8-K: Current report

Apr 30 16:28 ET

424B5: Prospectus

Apr 26 17:05 ET

Citius Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer HOLUBIAK MYRON Z

Apr 5 16:19 ET

Citius Pharmaceuticals | 8-K: Current report

Apr 5 16:16 ET

Citius Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Mazur Leonard L

Apr 5 16:09 ET

Citius Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Smith Robert Joseph

Mar 18 16:14 ET

Citius Pharmaceuticals | 8-K: Current report

Mar 18 16:13 ET

Citius Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Smith Robert Joseph

Mar 18 16:06 ET

Citius Pharmaceuticals | 8-K: Current report

Mar 13 16:38 ET

Citius Pharmaceuticals | EFFECT: Others

Mar 4 06:05 ET

Citius Pharmaceuticals | UPLOAD: Others

Feb 29 13:53 ET

Citius Pharmaceuticals | CORRESP: CORRESP

Feb 29 13:53 ET

Citius Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers

Feb 23 16:30 ET

Citius Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 23 16:26 ET

Citius Pharmaceuticals | 8-K: Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2024 Financial Results and Provides Business Update

Feb 15 08:47 ET

Citius Pharmaceuticals | 10-Q: Quarterly report

Feb 14 16:47 ET